Did Barbara Comstock buy Alnylam Pharmaceuticals stock?

Common questions

Did Barbara Comstock buy Alnylam Pharmaceuticals stock?

Yes. Barbara Comstock disclosed 1 purchase and 1 sale of Alnylam Pharmaceuticals (ALNY) stock between Oct 12, 2017 and Mar 5, 2018, in STOCK Act reports. Added together, the disclosed purchases come to $15K-$50K and the disclosed sales to $15K-$50K.

How big were Barbara Comstock's Alnylam Pharmaceuticals trades?

STOCK Act reports give a range for each trade, such as $15K-$50K, never an exact amount. Added together, the disclosed purchases come to $15K-$50K and the disclosed sales to $15K-$50K.

Did Barbara Comstock make these Alnylam Pharmaceuticals trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Barbara Comstock still own Alnylam Pharmaceuticals stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Barbara Comstock report these trades?

The latest filing is dated Mar 19, 2018. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.